Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
Atavistik Bio, Inc
Wake Forest University Health Sciences
K36 Therapeutics, Inc.
Varian, a Siemens Healthineers Company
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
University of California, Davis
National Institutes of Health Clinical Center (CC)
University of California, Irvine
Blue Earth Therapeutics Ltd
Washington University School of Medicine
Cedars-Sinai Medical Center
Spanish Oncology Genito-Urinary Group
Indiana University
H. Lee Moffitt Cancer Center and Research Institute
Centre Hospitalier Universitaire de Nīmes
National Institutes of Health Clinical Center (CC)
NanOlogy, LLC
Wake Forest University Health Sciences
Dana-Farber Cancer Institute
University Health Network, Toronto
AgonOx, Inc.
Memorial Sloan Kettering Cancer Center
Indiana University
RenJi Hospital
M.D. Anderson Cancer Center
Eli Lilly and Company
The Netherlands Cancer Institute
City of Hope Medical Center
Jinling Hospital, China
Queen Mary University of London
Pathos AI, Inc.
University of California, San Francisco
University of Washington
Johns Hopkins University
British Columbia Cancer Agency
Dana-Farber Cancer Institute
RefleXion Medical
Milton S. Hershey Medical Center
Universitaire Ziekenhuizen KU Leuven
Ottawa Hospital Research Institute
Marengo Therapeutics, Inc.
Eli Lilly and Company
Centre of Postgraduate Medical Education
University of California, Irvine
Endocyte